Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Mannequinon Apr 11, 2024 12:03pm
79 Views
Post# 35983487

RE:Dilutions

RE:Dilutions

I beleive they can only pay off $40M starting July. So not too certain that they need to raise too much to do that. And, if they did a partnership with $20M, they would have enough.

 

Trogarzon wrote: With sales all over the place in Q1 I would'nt be surprise they throw us under the bus one last time in order to get reelected of course and justify the use of proceeds by dept repayment and general admin expenses.  They have a shelve one for 100M usd already in place and IQ.  Provided they stay above 1$ usd I guess.  It's on my mind since the CFO said tehy were thinking of ways to repay shylock Marathon faster maybe.  All excuse are good for them except from delevering deals and results to prevent such dilutions.

 

<< Previous
Bullboard Posts
Next >>